• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素样生长因子与前列腺癌

Insulin-like growth factors and prostate cancer.

作者信息

Pollak M, Beamer W, Zhang J C

机构信息

Jewish General Hospital-McGill University, Montreal, Quebec, Canada.

出版信息

Cancer Metastasis Rev. 1998;17(4):383-90. doi: 10.1023/a:1006154108619.

DOI:10.1023/a:1006154108619
PMID:10453282
Abstract

Converging data from epidemiological and biological research implicate insulin-like growth factor (IGF) physiology in the regulation of prostate epithelial cell proliferation and in the pathophysiology of prostate cancer. This review (1) outlines elements of IGF physiology, (2) reviews recent evidence that circulating IGF-I level is related to risk of prostate cancer, (3) provides a hypothesis concerning the biological basis for the relationship between IGF-I level and risk of prostate cancer, (4) discusses IGF-I physiology in the context of neoplastic progression of prostate cancer, and (5) discusses clinical implications of these lines of research with respect to prevention and treatment.

摘要

来自流行病学和生物学研究的汇聚数据表明,胰岛素样生长因子(IGF)生理机能在前列腺上皮细胞增殖调节及前列腺癌病理生理学中发挥作用。本综述:(1)概述IGF生理机能的要素;(2)回顾循环IGF-I水平与前列腺癌风险相关的最新证据;(3)提出关于IGF-I水平与前列腺癌风险之间关系的生物学基础的假说;(4)在前列腺癌肿瘤进展的背景下讨论IGF-I生理机能;(5)讨论这些研究方向在预防和治疗方面的临床意义。

相似文献

1
Insulin-like growth factors and prostate cancer.胰岛素样生长因子与前列腺癌
Cancer Metastasis Rev. 1998;17(4):383-90. doi: 10.1023/a:1006154108619.
2
Insulin-like growth factors and prostate cancer.胰岛素样生长因子与前列腺癌
World J Urol. 2001 Aug;19(4):225-33. doi: 10.1007/s003450100220.
3
The effect on the insulin-like growth factor system in human prostate epithelial cells of immortalization and transformation by simian virus-40 T antigen.猿猴病毒40 T抗原对人前列腺上皮细胞永生化和转化过程中胰岛素样生长因子系统的影响。
J Clin Endocrinol Metab. 1996 Oct;81(10):3709-16. doi: 10.1210/jcem.81.10.8855827.
4
Interactions of the Insulin-Like Growth Factor Axis and Vitamin D in Prostate Cancer Risk in the Prostate Cancer Prevention Trial.在前列腺癌预防试验中胰岛素样生长因子轴与维生素D对前列腺癌风险的相互作用
Nutrients. 2017 Apr 12;9(4):378. doi: 10.3390/nu9040378.
5
Insulin-like growth factor (IGF) and bone.胰岛素样生长因子(IGF)与骨骼
Connect Tissue Res. 1989;20(1-4):277-82. doi: 10.3109/03008208909023897.
6
The influence of dietary intake on the insulin-like growth factor (IGF) system across three ethnic groups: a population-based study.饮食摄入对三个种族群体胰岛素样生长因子(IGF)系统的影响:一项基于人群的研究。
Public Health Nutr. 2003 Apr;6(2):175-80. doi: 10.1079/PHN2002414.
7
Insulin-like growth factor (IGF) binding protein-3 attenuates prostate tumor growth by IGF-dependent and IGF-independent mechanisms.胰岛素样生长因子(IGF)结合蛋白-3通过依赖IGF和不依赖IGF的机制减弱前列腺肿瘤的生长。
Endocrinology. 2006 May;147(5):2112-21. doi: 10.1210/en.2005-1270. Epub 2006 Feb 9.
8
Insulin-like growth factors and prostate cancer: a population-based case-control study in China.胰岛素样生长因子与前列腺癌:一项基于中国人群的病例对照研究。
Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):421-7.
9
Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: A nested case-control study in large scale cohort study in Japan.胰岛素样生长因子(IGF)-I及IGF结合蛋白-3与前列腺癌风险的关系:日本一项大规模队列研究中的巢式病例对照研究
Asian Pac J Cancer Prev. 2009 Dec;10 Suppl:57-61.
10
Novel insights into the implication of the IGF-1 network in prostate cancer.对胰岛素样生长因子-1(IGF-1)网络在前列腺癌中的作用的新见解。
Trends Mol Med. 2005 Feb;11(2):52-5. doi: 10.1016/j.molmed.2004.12.005.

引用本文的文献

1
The IGF-Independent Role of IRS-2 in the Secretion of MMP-9 Enhances the Growth of Prostate Carcinoma Cell Line PC3.IRS-2 在 MMP-9 分泌中的 IGF 非依赖性作用增强了前列腺癌细胞系 PC3 的生长。
Int J Mol Sci. 2023 Oct 11;24(20):15065. doi: 10.3390/ijms242015065.
2
Diabetes and Prostate Cancer Outcomes in Men with Nonmetastatic Castration-Resistant Prostate Cancer: Results from the SEARCH Cohort.糖尿病与非转移性去势抵抗性前列腺癌男性患者的前列腺癌结局:SEARCH 队列研究结果。
Cancer Epidemiol Biomarkers Prev. 2023 Sep 1;32(9):1208-1216. doi: 10.1158/1055-9965.EPI-22-1324.
3
Physical resistance training-induced changes in lipids metabolism pathways and apoptosis in prostate.
物理抵抗训练引起前列腺中脂质代谢途径和细胞凋亡的变化。
Lipids Health Dis. 2020 Jan 29;19(1):14. doi: 10.1186/s12944-020-1195-0.
4
IRS-2 deubiquitination by USP9X maintains anchorage-independent cell growth via Erk1/2 activation in prostate carcinoma cell line.USP9X对IRS-2的去泛素化作用通过激活Erk1/2维持前列腺癌细胞系的非锚定依赖性细胞生长。
Oncotarget. 2018 Sep 21;9(74):33871-33883. doi: 10.18632/oncotarget.26049.
5
Molecular Imaging of IGF-1R in Cancer.癌症中胰岛素样生长因子-1受体(IGF-1R)的分子成像
Mol Imaging. 2017 Jan-Dec;16:1536012117736648. doi: 10.1177/1536012117736648.
6
Insulin-like growth factor 1 receptor affects the survival of primary prostate cancer patients depending on TMPRSS2-ERG status.胰岛素样生长因子1受体根据跨膜丝氨酸蛋白酶2-ETS相关基因(TMPRSS2-ERG)状态影响原发性前列腺癌患者的生存率。
BMC Cancer. 2017 May 25;17(1):367. doi: 10.1186/s12885-017-3356-8.
7
Interactions of the Insulin-Like Growth Factor Axis and Vitamin D in Prostate Cancer Risk in the Prostate Cancer Prevention Trial.在前列腺癌预防试验中胰岛素样生长因子轴与维生素D对前列腺癌风险的相互作用
Nutrients. 2017 Apr 12;9(4):378. doi: 10.3390/nu9040378.
8
Is there a role for IGF-1 in the development of second primary cancers?胰岛素样生长因子-1(IGF-1)在第二原发性癌症的发生发展中起作用吗?
Cancer Med. 2016 Nov;5(11):3353-3367. doi: 10.1002/cam4.871. Epub 2016 Oct 13.
9
Inhibition of insulin-like growth factor II (IGF-II)-dependent cell growth by multidentate pentamannosyl 6-phosphate-based ligands targeting the mannose 6-phosphate/IGF-II receptor.通过靶向甘露糖6-磷酸/胰岛素样生长因子II受体的基于多齿五甘露糖基6-磷酸的配体抑制胰岛素样生长因子II(IGF-II)依赖性细胞生长。
Oncotarget. 2016 Sep 20;7(38):62386-62410. doi: 10.18632/oncotarget.11493.
10
ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents.视网膜电图失调会诱导前列腺癌细胞中胰岛素样生长因子-1受体(IGF-1R)的表达,并影响对抗IGF-1R药物的敏感性。
Oncotarget. 2015 Jun 30;6(18):16611-22. doi: 10.18632/oncotarget.3425.